CEACAM5 and cancer: The discovery of diagnostic glycoprotein markers by the trapped glycoproteins utilizing lectins or other glycan-binding antibodies has proffered the detection of glycosylation between cancer and healthy controls.46 MUC1, MUC16, carcinoembryonic antigen (CEA), and prostate-specific antigen (PSA) are some of the examples of glycoprotein diagnostic biomarkers.